Detalhe da pesquisa
1.
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.
Am J Hematol
; 97(9): 1159-1169, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35726449
2.
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma.
Blood
; 132(11): 1146-1158, 2018 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30054295
3.
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes.
Mol Cancer
; 20(1): 134, 2021 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34654425
4.
Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide.
Clin Epigenetics
; 15(1): 19, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36740715
5.
Role of PET imaging in peritoneal involvement of subcutaneous panniculitis-like T-cell lymphoma.
J Radiol Case Rep
; 16(6): 1-11, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35875366
6.
Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint.
EBioMedicine
; 83: 104216, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35986950
7.
High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma.
Blood Cancer J
; 11(8): 143, 2021 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34385415
8.
CREBBP cooperates with the cell cycle machinery to attenuate chidamide sensitivity in relapsed/refractory diffuse large B-cell lymphoma.
Cancer Lett
; 521: 268-280, 2021 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34481935
9.
Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.
Leukemia
; 35(4): 1225, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686199
10.
Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.
Leukemia
; 34(12): 3413-3419, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32753688